Litcius/Paper detail

Discovery of pyrimidine-bridged CA-4 CBSIs for the treatment of cervical cancer in combination with cisplatin with significantly reduced nephrotoxicity

Zhipeng Huo, Kunlin Liu, Xi Zhang, Yongxi Liang, Xun Sun

2022European Journal of Medicinal Chemistry10 citationsDOIOpen Access PDF

Topics & Concepts

HeLaCisplatinChemistryPharmacologyIC50ApoptosisNephrotoxicityToxicityCell cycleCancer researchIn vitroChemotherapyBiochemistryInternal medicineMedicineOrganic chemistryCancer Mechanisms and TherapyCancer therapeutics and mechanismsFerrocene Chemistry and Applications
Discovery of pyrimidine-bridged CA-4 CBSIs for the treatment of cervical cancer in combination with cisplatin with significantly reduced nephrotoxicity | Litcius